Inozyme director Hopfner buys $1.6M in company shares

Inozyme Pharma Director Robert Hopfner disclosed in a regulatory filing, that he had purchased 344,592 shares of company stock at $4.54 per share on March 29, for a total transaction amount of $1,563,724.